The Surprising Over-the-Counter Pain Reliever Consumers ...
www.fool.com/.../the-surprising-over-the-counter-pain-...
The Motley Fool
Sep 6, 2014 - The over-the-counter drug market could grow to reach $70 billion in sales by 2015, but according to Brand Keys, this OTC pain reliever is ... this year and ranked these six pain relievers listed above from top to bottom in ... If you guessed Tylenol, an OTC drug offered by Johnson & Johnson (NYSE: JNJ ) ...
70 BILLION per year. That's BILLION and that's 70, not 5, 8, 10 etc.
Pain relief is big business to say the least. There is no doubt this is the biggest business for medicinal OTC non prescriptive and prescribed drugs. Man will always buy ANY product that will relieve pain. Immediate relief NOW overrides side affects that may occur later in life. That is the mantra now without an alternative. The choice is simple at this point:, Pain vs pain relief with the threat of side affects. We have no other choice in this country. And because actipatch and its fellow products COULD be that alternative and a possible choice by US citizens, it is a CRIME that they/we are not allowed this choice.
IF Bioelectronics can capture 1% of pain relief market, that would be $700 million. With 8 billion shares outstanding and a even P/E, that would result in a stock price of .0875. I'll take that now. Most all companies trade at a higher P/E, as the market is forward looking, so a higher price could most definitely be justified. That is at only at 1% of market. As word and usage justify the validity of these products, a higher market share very much could result. If we want to be optimistic, lets go for 5% of market: $3.5 billion which calculates to .4375 stock price with 8 billion shares outstanding. Even at one half percent (.005) of potential market ($350 mil) we are looking at a stock price of .04375.
BIG business in this sector.
